Ac-225-PSMA-617 apparently extends survival of very late-stage patients: an update

Posted on December 23, 2016 by Sitemaster

The nuclear medicine group at the University of Heidelberg in Germany recently reported a complete response in two patients treated with Ac-225-PSMA-617 (see this link). … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: , , , | 6 Comments »

The language of denial of access to high-quality prostate cancer care today

Posted on October 24, 2016 by Sitemaster

If you look at the corporate web site for eviCore Healthcare, the company describes itself as follows: … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: , , , | 6 Comments »

  • Donate

  • PCaI’s ASVSG

    If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.

  • CureTalks on PCa

    Our most recent CureTalk on Prostate Cancer (on February 21 this year)  features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.

    For access to the full list of CureTalks on Prostate Cancer, please click here.

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives